LONDON, England, Feb. 9 -- Future Oncology, a journal that says it provides a forum for a new era of cancer care, published research articles on the following topics in its Vol. 17, No. 4 edition:

Drug Evaluation:

* An update of venetoclax and obinutuzumab in chronic lymphocytic leukemia

* Pemigatinib, a potent inhibitor of FGFRs for the treatment of cholangiocarcinoma

Short Communication:

* Exploratory analysis of the platelet-t . . .

Click here for more information about our products